Regulatory Compliance Harman Finochem’s manufacturing facilities are fully compliant with cGMP standards recognized by major regulators such as USFDA, ICH, TGA, PIC, WHO, and Japanese authorities, ensuring high-quality API production that appeals to global pharmaceutical companies seeking reliable manufacturing partners.

Expansion Capacity With multiple state-of-the-art manufacturing sites and a capacity of 350,000 liters, the company is well-positioned to scale production and meet increasing demand from pharma and generic firms, offering opportunities to clients looking for dependable API supply chains.

Export Expertise Recognized as an 'Export House' by the Indian government, Harman Finochem has established a strong export footprint, making it an attractive partner for international pharma companies seeking high-quality APIs and intermediates for global distribution.

Technology and Quality The company employs advanced manufacturing techniques including pneumatic processing, micronising, and particle size control, supported by state-of-the-art GLP-compliant laboratories—ideal for clients prioritizing innovative, quality-assured pharmaceutical ingredients.

Financial Stability With revenue estimated between $100 million and $250 million and a sizable workforce, Harman Finochem demonstrates a solid market presence and growth potential, making it a dependable supplier for large-scale pharmaceutical API orders.